OKYO Pharma Limited (OKYO)
NASDAQ: OKYO · IEX Real-Time Price · USD
1.500
+0.060 (4.17%)
At close: Mar 27, 2024, 4:00 PM
1.490
-0.010 (-0.67%)
After-hours: Mar 27, 2024, 7:57 PM EDT

OKYO Pharma Income Statement

Millions USD. Fiscal year is Apr - Mar.
Year 2022202120202019
Selling, General & Admin
6.854.613.021.02
Research & Development
6.341.610.350.52
Operating Expenses
13.196.223.371.53
Operating Income
-13.19-6.22-3.37-1.53
Interest Expense / Income
0.1000
Other Expense / Income
--0.010.08
Pretax Income
-13.28-6.22-3.38-1.62
Income Tax
-0.01-0.79-0.02-0.08
Net Income
-13.27-5.43-3.35-1.54
Shares Outstanding (Basic)
282222-
Shares Change
29.71%---
EPS (Basic)
-0.61-0.36-0.32-
EPS (Diluted)
-0.61-0.36-0.32-
Free Cash Flow
-7.7-5.47-1.61-1.2
Free Cash Flow Per Share
-0.27-0.25-0.07-
EBITDA
-13.18-6.22-3.36-1.61
Depreciation & Amortization
000.010.01
EBIT
-13.19-6.22-3.38-1.62
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).